Connecticut · 2025 Regular Session · Bill
SB 772: AN ACT CONCERNING OVERSIGHT AND TRANSPARENCY IN THE PRESCRIPTION OF PSYCHOTROPIC DRUGS TO CHILDREN RECEIVING BENEFITS UNDER MEDICAID.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 772 is a bill introduced in the Connecticut Senate on January 17, 2025. According to its official title, it concerns: AN ACT CONCERNING OVERSIGHT AND TRANSPARENCY IN THE PRESCRIPTION OF PSYCHOTROPIC DRUGS TO CHILDREN RECEIVING BENEFITS UNDER MEDICAID. Most recent recorded action (January 17, 2025): REF. TO JOINT COMM. ON Public Health.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REF. TO JOINT COMM. ON Public Health